Year-over-year articles
VISTIN PHARMA ASA
12 crawlable comparisons of consecutive annual reports.
Full company analysis · Org.nr 915 157 882
Shrank 100% on revenue, returned to profit, cash halved-plus
Comparing Årsregnskap 2025 with 2024 for VISTIN PHARMA ASA. Revenue 429.50m NOK → 452.3k NOK (-99.9%). Net result -3.53m NOK → +10.99m NOK. Equity 184.03m…
Grew 97887% on revenue
Comparing Årsregnskap 2024 with 2023 for VISTIN PHARMA ASA. Revenue 438.3k NOK → 429.50m NOK (+97886.7%). Net result -2.98m NOK → -3.53m NOK. Equity 265.15m…
Grew 44% on revenue, weaker earnings
Comparing Årsregnskap 2023 with 2022 for VISTIN PHARMA ASA. Revenue 304.9k NOK → 438.3k NOK (+43.8%). Net result -1.85m NOK → -2.98m NOK. Equity 268.13m NOK…
Grew 9% on revenue, weaker earnings, cash halved-plus
Comparing Årsregnskap 2022 with 2021 for VISTIN PHARMA ASA. Revenue 278.6k NOK → 304.9k NOK (+9.4%). Net result -2 558 NOK → -1.85m NOK. Equity 269.98m NOK…
Grew 10% on revenue, slipped into loss, cash halved-plus
Comparing Årsregnskap 2021 with 2020 for VISTIN PHARMA ASA. Revenue 253.9k NOK → 278.6k NOK (+9.7%). Net result +214.0k NOK → -2 558 NOK. Equity 294.71m NOK…
Weaker earnings, fresh owner capital
Comparing Årsregnskap 2020 with 2019 for VISTIN PHARMA ASA. Revenue 0 NOK → 253.9k NOK. Net result +3.13m NOK → +214.0k NOK. Equity 338.8k NOK → 294.71m NOK.
Grew 100% on revenue, cash halved-plus
Comparing Årsregnskap 2019 with 2018 for VISTIN PHARMA ASA. Revenue -5.50m NOK → 0 NOK (+100.0%). Equity 338.5k NOK → 338.8k NOK.
Shrank 107% on revenue, fresh owner capital
Comparing Årsregnskap 2018 with 2017 for VISTIN PHARMA ASA. Revenue 83.12m NOK → -5.50m NOK (-106.6%). Equity 112.93m NOK → 338.5k NOK.
Grew 20954% on revenue
Comparing Årsregnskap 2017 with 2016 for VISTIN PHARMA ASA. Revenue 394.8k NOK → 83.12m NOK (+20954.4%). Equity 163.61m NOK → 112.93m NOK.
Grew 73% on revenue, fresh owner capital
Comparing Årsregnskap 2016 with 2015 for VISTIN PHARMA ASA. Revenue 227.9k NOK → 394.8k NOK (+73.2%). Equity 170.52m NOK → 163.61m NOK.
Cash halved-plus, fresh owner capital
Comparing Årsregnskap 2015 with 2014 for VISTIN PHARMA ASA. Revenue 0 NOK → 227.9k NOK. Equity 0 NOK → 170.52m NOK.
First published accounts
First year in the published series for VISTIN PHARMA ASA (2014). No prior-year comparative in this dataset.